Answers are grounded in this paper and cite their sources.
An 80-year-old man with poorly differentiated squamous cell carcinoma underwent 18 F-FDG PET/CT for initial staging and treatment response assessment following pembrolizumab therapy. Follow-up PET/CT demonstrated a new FDG-avid focus within the T3 vertebral body without a corresponding CT abnormality. Subsequent contrast-enhanced MRI revealed no structural correlate at the site of uptake. A repeat PET/CT performed 3 months later showed complete resolution of the vertebral lesion without additional treatment. The imaging findings favored transient immune-related inflammatory uptake or a pseudoprogression-like phenomenon rather than true osseous metastasis.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: